Trastuzumab - Cancer Precision Medicine

Trastuzumab deruxtecan is an effective new treatment for patients with HER2-positive metastatic breast cancer who have been previously treated

Trastuzumab was developed by Genentech Inc as a recombinant humanized monoclonal antibody directed against the

trastuzumab Trastuzumab side effects · heart problems; · nausea, diarrhea, weight loss; · headache; · trouble sleeping, feeling tired; · low blood cell

trastuzumab Trastuzumab exposure for a relatively short period does not seem to substantially affect the pregnancy outcome In contrast, a more prolonged